Table 1.
Patient characteristics of SLE patients.
| Total (N = 63) | Non-HCQ (N = 49) | HCQ (N = 14) | |
|---|---|---|---|
| Race (n (%)) | |||
| Caucasian | 56 (89) | 45 (92) | 11 (79) |
| Black | 1 (2) | 1 (2) | 0 (0) |
| Asian | 6 (10) | 3 (6) | 3 (21) |
| Age at the start of the first registered pregnancy (mean (SD)) | 31.0 (4.1) | 30.6 (4.0) | 32.5 (4.3) |
| Disease duration at the start of the first registered pregnancy | 6.0 (3.0–10.0) | 6 (3.5–9.5) | 4.5 (3–10.8) |
| Number of registered pregnancies per patient | 1 (1-2) | 1 (1-2) | 2 (1-2) |
| Antiphospholipid antibodies present | 7 (11) | 6 (13) | 1 (7) |
| LAC (n (%))∗ | |||
| Negative | 58 (92) | 44 (90)∗ | 14 (100) |
| Positive | 4 (7) | 4 (9) | 0 (0) |
| aCL-IgG (n (%)) | |||
| Negative | 59 (94)∗ | 45 (92)∗ | 14 (100) |
| Positive | 3 (54) | 3 (6) | 0 (0) |
| aCL-IgM (n (%)) | |||
| Negative | 61 (97)∗ | 48 (98)∗ | 13 (93) |
| Positive | 1 (2) | 0 (0) | 1 (7) |
SD: standard deviation; IQR: interquartile range. Age and disease duration in years. Data depicted as median (IQR) unless otherwise indicated. ∗Unknown: n = 1. Anti-beta2 glycoprotein IgG/IgM was tested in 31 patients in whom it was all negative.